Q-omics Yearly License

Q-omics is a cloud-based AI platform designed to simplify large-scale multi-omics data analysis for life science researchers. Traditional omics analysis requires specialized bioinformatics skills, fragmented tools, and significant time to integrate and interpret complex datasets. Q-omics addresses this challenge by providing an integrated SaaS solution for intuitive, end-to-end data mining and interpretation.

The platform integrates a large-scale omics meta-database with proprietary AI technologies, including Bio-LDM (Biological Large Data Model) and LLM-based workflows, to automate analysis. Users can explore literature, gene expression, mutation, proteomics, drug response, and clinical associations across datasets without coding or relying on bioinformatics experts.

Built on AWS, Q-omics leverages scalable cloud infrastructure to process large biological datasets and deliver fast, reliable results. It supports near real-time analysis, enabling researchers to generate hypotheses and validate findings for target discovery, biomarker identification, and mechanism studies.

Q-omics is applicable across academia, biotech, pharmaceutical companies, and clinical research organizations. It supports use cases such as identifying therapeutic targets, discovering biomarkers, analyzing drug response, and understanding disease mechanisms.

By reducing the complexity of multi-omics analysis and making advanced analytics accessible to non-experts, Q-omics improves research productivity and accelerates early-stage drug discovery.